Single-cell RNA sequencing (scRNA-seq) is a powerful approach for reconstructing cellular differentiation trajectories. However, inferring both the state and direction of differentiation is challenging. Here, we demonstrate a simple, yet robust, determinant of developmental potential-the number of expressed genes per cell-and leverage this measure of transcriptional diversity to develop a computational framework (CytoTRACE) for predicting differentiation states from scRNA-seq data. When applied to diverse tissue types and organisms, CytoTRACE outperformed previous methods and nearly 19,000 annotated gene sets for resolving 52 experimentally determined developmental trajectories. Additionally, it facilitated the identification of quiescent stem cells and revealed genes that contribute to breast tumorigenesis. This study thus establishes a key RNA-based feature of developmental potential and a platform for delineation of cellular hierarchies.
I n multicellular organisms, tissues are hierarchically organized into distinct cell types and cellular states with intrinsic differences in function and developmental potential (1) . Common methods for studying cellular differentiation hierarchies, such as lineage tracing and functional transplantation assays, have revealed detailed roadmaps of cellular ontogeny at scales ranging from tissues and organs to entire model organisms (2) (3) (4) . Though powerful, these technologies cannot be applied to human tissues in vivo and generally require prior knowledge of cell type-specific genetic markers (2) . These limitations have made it difficult to study the developmental organization of primary human tissues under physiological and pathological conditions.
Single-cell RNA-sequencing (scRNA-seq) has emerged as a promising approach to study cellular differentiation trajectories at high resolution in primary tissue specimens (5) . Although a large number of computational methods for predicting lineage trajectories have been described, they generally rely upon (i) a priori knowledge of the starting point (and thus, direction) of the inferred biological process (6, 7) and (ii) the presence of intermediate cell states to reconstruct the trajectory (8, 9) . These requirements can be challenging to satisfy in certain contexts, such as human cancer development (10) . Moreover, with existing in silico approaches, it is difficult to distinguish quiescent (noncycling) adult stem cells that have long-term regenerative potential from more specialized cells. Although gene expression-based models can potentially overcome these limitations [e.g., transcriptional entropy (11) (12) (13) , pluripotency-associated gene sets (14) , and machine learning strategies (15) ], their utility across diverse developmental systems and single-cell sequencing technologies is still unclear.
Here, we systematically evaluated RNA-based features, including nearly 19,000 annotated gene sets, to identify factors that accurately predict cellular differentiation status independently of tissue type, species, and platform. We then leveraged our findings to develop an unsupervised framework for predicting relative differentiation states from single-cell transcriptomes. We validated our approach through comparison to leading methods and explored its utility for identifying key genes associated with stem cells and differentiation in both healthy tissues and human cancer.
Results

RNA-based correlates of single-cell differentiation states
Our initial goal was to identify robust, RNAbased determinants of developmental poten-tial without the need for a priori knowledge of developmental direction or intermediate cell states marking cell fate transitions. Using scRNA-seq data, we evaluated~19,000 potential correlates of cell potency, including all available gene sets in the Molecular Signatures Database (n = 17,810) (16) , 896 gene sets covering transcription factor binding sites from ENCODE (17) and ChEA (18) , an mRNA expression-derived stemness index (mRNAsi) (15) , and three computational techniques that infer stemness as a measure of transcriptional entropy [StemID, SCENT, and SLICE (11) (12) (13) ]. We also explored the utility of "gene counts," or the number of detectably expressed genes per cell. Although anecdotally observed to correlate with differentiation status in a limited number of settings [alveolar development in mouse and thrombocyte development in zebrafish (19, 20) ], the reliability of this association and whether it reflects a general property of cellular ontogeny are unknown.
To assess these RNA-based features, we compiled a training cohort consisting of nine gold standard scRNA-seq datasets with experimentally confirmed differentiation trajectories. These datasets were selected to prioritize commonly used benchmarking datasets from earlier studies and to ensure a broad sampling of developmental states from the mammalian zygote to terminally differentiated cells (table  S1) . Overall, the training cohort encompassed 3174 single cells spanning 49 phenotypes, six biological systems, and three scRNA-seq platforms (fig. S1A and table S1). To evaluate performance, we used Spearman correlation to compare each RNA-based feature, averaged by phenotype, against known differentiation states ( Fig. 1A) . We then averaged the results across the nine training datasets to yield a final score and rank for every feature (table S2) .
This systematic screen revealed many known and unexpected correlates of differentiation status (Fig. 1B, fig. S1B , and table S2). However, one feature in particular showed notable performance: the number of detectably expressed genes per cell (gene counts). Appearing in the top 1% of the ranked list (104 of 18,711), this data-driven feature compared favorably to well-established stem cell signatures, including cell cycle and pluripotency genes (14, 15) , yet also showed evidence of distinctive biology and broader applicability. For example, regardless of whether we examined cycling cells, noncycling cells, or published data from the earliest stages of human embryogenesis prior to the up-regulation of pluripotency factors (21) , gene counts generally decreased with successive stages of differentiation (fig. S2, A and B, left). Pluripotency genes, by contrast, showed an arc-like pattern early in human embryogenesis that was characterized by progressively increasing expression until the emergence of embryonic stem cells, followed by decreasing expression ( fig. S2B , right).
These findings suggested that gene counts might extend beyond isolated experimental systems to recapitulate the full spectrum of developmental potential. To test this possibility, we compiled, remapped, and normalized a set of in vivo mouse lineage trajectories based on five plate-based scRNA-seq experiments encompassing 5059 cells and 30 phenotypes that together spanned all major potency levels (22) (table S3 and materials and methods). Indeed, when averaged according to known phenotypes and assessed across independent studies, the association between gene counts and differentiation was maintained (R 2 = 0.89, P = 1.8 × 10 −8 ) ( Fig. 1C and materials and methods). Notably, this relationship was also observed in other organisms, including Caenorhabditis elegans ( Fig. 1D ) and zebrafish (table S4), suggesting that it is a general feature of cellular ontogeny.
Because the transcriptional output of a cell is associated with its genome-wide chromatin profile, we next tested whether single-cell gene counts are ultimately a surrogate for global chromatin accessibility, which has been shown to decrease with differentiation in certain contexts (23) (24) (25) . To do this, we compared single-cell gene counts derived from scRNA-seq data with paired bulk ATAC-seq (assay for transposaseaccessible chromatin sequencing) profiles obtained from a recent study of in vitro mesodermal differentiation from human embryonic stem cells (hESCs) (26) . Indeed, genome-wide chromatin accessibility was observed to progressively decrease with differentiation of hESCs into paraxial mesoderm and lateral mesoderm lineages ( Fig. 1E and fig. S3 , A and B). We observed strong concordance between the number of accessible peaks and the mean number of detectably expressed genes per phenotype 
Development of CytoTRACE
The number of expressed genes per cell generally showed consistent performance with respect to key technical parameters and was generally correlated with mRNA content (figs. S4 to S7 and supplementary text). However, in some datasets, such as that for in vitro differentiation of hESCs into the gastrulation layers (27) , the number of expressed genes per cell exhibited considerable intraphenotypic variation ( Fig. 2A, left) . Indeed, when evaluated at a single-cell level, 412 predefined gene sets from our in silico screen outperformed gene counts ( fig. S8A and table S2 ). Because scRNA-seq was designed to capture single-cell gene expression, we reasoned that genes whose expression patterns correlate with gene counts might better capture differentiation states. Indeed, by simply averaging the expression levels of genes that were most highly correlated with gene counts in each dataset (materials and methods), the resulting dataset-specific gene counts signature (GCS) became the topperforming measure in the screen, outranking every predefined gene set and computational tool that we assessed ( fig. S8 , A to D).
GCS, like gene counts, is inherently insensitive to dropout events, is agnostic to prior knowledge of developmentally regulated genes, and is not solely attributable to multilineage priming (28) ( fig. S9 and supplementary text) or a known molecular signature (e.g., pluripotency) ( fig. S2B and table S5). Despite these characteristics, GCS was still moderately noisy in some datasets (e.g., Fig. 2A, center and fig. S8C ). We therefore implemented a two-step procedure to directly smooth GCS on the basis of transcriptional covariance among single cells ( Fig. 2A 
Performance evaluation across tissues, species, and platforms
To validate our findings, we assembled an expanded compendium of 33 additional scRNAseq datasets from 26 studies (fig. S10A, table S1, and materials and methods). These datasets represent diverse developmental and differentiation processes and consist of 141,267 single cells spanning 266 phenotypes, nine biological systems, five species [including two whole organisms (29, 30) ], and nine scRNAseq platforms (three droplet-based and six platebased protocols, ranging from an average of~10,000 unique molecular identifiers tõ 1 million reads per cell, respectively) ( fig. S5A ). When assessed at the single-cell level, CytoTRACE outperformed all evaluated RNAbased features in the validation cohort ( Fig.  2B) , achieving a substantial gain in performance over the second-highest-ranking approach (median rho = 0.72 versus 0.53 for the secondhighest-ranking approach; P = 0.001) ( Fig.  2C; fig. S10B ; and tables S2 and S4). Similar improvements were observed across many complex systems, including bone marrow differentiation ( fig. S10C ). In addition, CytoTRACE results were positively correlated with the direction of differentiation in 88% of datasets (P = 7 × 10 -7 , binomial test). These results were consistent with our findings for the training cohort ( Fig. 2B and fig. S10D ) and were robust to the use of smoothing ( fig. S11) versus snapshots of developmental states, or plate-based versus droplet-based technologies ( fig. S12 ).
To further evaluate CytoTRACE, we compared it with RNA velocity, a kinetic model that can predict future cell states but is limited to scRNA-seq data with continuous fate transitions (8) . To analyze RNA velocity output, which consists of an individualized prediction for every cell (fig. S13 ), we identified all pairs of current and future cell states spanning a known shift in developmental potential (in the order of less to more, or vice versa). We then scored each predicted trajectory against known differentiation states on five datasets with continuous developmental processes (fig. S13B and materials and methods). To permit a fair comparison, CytoTRACE was evaluated on the same cells. Although both methods performed similarly on an embryonic chromaffin dataset from the RNA velocity study (8) , CytoTRACE achieved higher accuracy overall (median of 74% versus 54%, respectively;
fig. S13C). This was likely due to the short mRNA half-lives and developmental time scales assumed for the RNA velocity model (8) (supplementary text).
Having assessed performance on individual datasets, we next asked whether CytoTRACE could be applied across independent scRNAseq datasets unified by batch correction. To address this, we leveraged mutual nearestneighbor and Gaussian kernel normalization techniques from Scanorama (31) (materials and methods). We then merged several datasets with this approach. Regardless of whether we integrated datasets profiled on different scRNAseq platforms (Fig. 3A) or datasets containing developmentally distinct cell types ( fig. S14 ), single-cell orderings predicted by CytoTRACE were accurate.
Stem cell-related genes and hierarchies
Given the ability of CytoTRACE to recover the direction of differentiation in nearly every evaluated dataset (supplementary text), we next explored its potential to identify markers of immature phenotypes without prior knowledge. By rank-ordering genes on the basis of their correlation with CytoTRACE, markers of immature cells were readily prioritized in 86% of benchmarking datasets ( fig. S15A ). These included well-established stem and progenitor markers, such as Kit and Stmn1 in mouse bone marrow (32) and Axin2 and Lgr5 in mouse intestinal crypts (33) , underscoring the utility of CytoTRACE for the de novo discovery of developmentally regulated genes ( fig.  S15B and table S6) . Lineage relationships and their associated genes can also be determined by dedicated branch detection tools, such as Monocle 2; however, these approaches do not predict the starting point of the biological process. For example, when applied to 4442 bone marrow cells, Monocle 2 identified 23 possible "roots" from which to calculate pseudotime values ( Fig. 3B, left ( Fig. 3B, right, and fig. S16, A and B) . Integration of these methods facilitated automatic identification of lineage-specific regulatory factors and marker genes during granulocyte, monocyte, and B cell differentiation ( fig. S16C ). Similar results were obtained for mouse intestinal cells ( fig. S16, D to F) . Notably, other methods also showed strong performance when oriented by CytoTRACE ( fig. S16G and table S4 ). We next asked whether CytoTRACE could distinguish cycling and long-term or quiescent stem cells from their downstream progenitors (34) . As these populations have been wellcharacterized in the bone marrow (3), we investigated this question in the mouse hematopoietic system. Although both cycling and quiescent hematopoietic stem cell (HSC) subpopulations (34) were correctly predicted to be less differentiated, only proliferative HSCs were significantly ranked above early progenitors (Fig. 3C ). This result was not unexpected, however, because quiescent cells have reduced metabolic activity and low RNA content (1). By devising a simple approach to visualize inferred RNA content as a function of CytoTRACE (Fig. 3D, top) , we observed a distinct valley in RNA abundance that coincided with elevated expression of Hoxb5, a marker of long-term or quiescent HSCs (35) (Fig. 3D , bottom). Since these cells could not be identified by gene counts or RNA content alone, this analysis confirmed the utility of CytoTRACE and demonstrated an approach for elucidating tissue-specific stem cells from scRNA-seq data.
Application to neoplastic disease
Increasing evidence suggests that human breast tumors contain less-differentiated cells that are resistant to therapy and are associated with the development of relapse and metastasis (10, 36) . 
Top ranking genes give rise to aggressive basal-like breast cancers, such as triple-negative breast cancer (TNBC) (37) , and possibly also to estrogen receptor-positive (ER+) breast cancers (38) . However, the differentiation states and tumor-initiating properties of LP subsets remain incompletely understood.
To determine whether CytoTRACE can provide insights into immature LP cells and their associated genes in breast cancer, we performed scRNA-seq profiling of breast tumor epithelial cells and adjacent normal epithelial cells from eight patients with triple-negative (n = 2) or ER+ (n = 6) breast cancer. Using a Smart-seq2 protocol combined with fluorescenceactivated cell sorting (FACS), we index-sorted and sequenced cells from three major human epithelial subpopulations: basal (CD49f high EPCAM med-low ), luminal progenitor (CD49f high EPCAM high ), and mature luminal (ML) subpopulations (CD49f low EPCAM high ) ( fig. S17A and table S7). After removing low-quality cells and applying principal component analysis to visualize the data, we confirmed three wellseparated clusters of basal, LP, and ML cells, each with characteristic expression patterns of previously described lineage markers ( Fig. 4A  and fig. S17B ). No obvious clustering was observed for tumor versus normal cell differences or by patient ( Fig. 4A and fig. S18A ).
To validate the ability of CytoTRACE to define LP differentiation states, we started by rank-ordering genes expressed in adjacent normal LPs by their Pearson correlation with CytoTRACE. We found that previously described marker genes of less-differentiated normal LPs [ALDH1A3 and MFGE8 (39)] and more-differentiated normal LPs [GATA3, FOXA1, and AR (39, 40)] were successfully enriched by this approach (Fig. 4B) . Moreover, genes that were up-regulated in highly clonogenic normal LPs (39) were skewed toward genes predicted to mark less-differentiated cells (Fig. 4B ).
We next sought to identify LP genes associated with tumorigenesis. We first ordered genes expressed in malignant LPs by their Pearson correlation with CytoTRACE. In this rank-ordered list, we observed a significant enrichment of genes whose knockdown by RNA interference (RNAi) led to decreased viability of tumor cells in patient-derived xenograft (PDX) models of TNBC (41) (Q = 0.002, gene set enrichment analysis) ( Fig. 4C; fig. S18 , B and C; and table S8). Moreover, when we applied CytoTRACE to prioritize genes in tumor LPs compared to tumor MLs, the latter of which are developmentally downstream of LPs in normal breast (39) , the top 15 genes included known members of tumorigenic pathways in breast cancer [e.g., MET and JAK1 (42, 43)], as well as unknown candidates (e.g., GULP1) (Fig. 4D, top) . We focused on genes that were (i) more highly expressed in tumor LPs than MLs and (ii) expressed in a subpopulation of tumor LPs (<20% of cells) (Fig. 4D, bottom) . After applying this filter, GULP1 emerged as the top candidate gene (Fig. 4D, bottom right, and fig. S18C ).
GULP1 is an engulfment adaptor protein (44) and its murine homolog is a specific marker of mouse HSCs, suggesting a conserved role of this gene in other immature cell states (fig. S19A). We measured the effect of GULP1 knockdown on the proliferation of the metastatic TNBC cell lines MDA-MB-231 and MDA-MB-468 ( fig. S19, B to E). We found that GULP1 knockdown reduced proliferation of both cell lines as measured by a colorimetric assay for metabolic activity (fig. S19E ). In addition, GULP1 knockdown in PDXs (n = 2) either inhibited tumor growth (TNBC sample) or fully abrogated tumor growth (ER+ sample) ( Fig. 4, E and F) . These data suggest a possible role for GULP1 in human breast cancer tumorigenesis.
Discussion
Efforts to characterize single-cell transcriptomes in diverse tissues, organs, and whole organisms have underscored the need for RNAbased determinants of developmental potential. In our analysis of RNA-based features across numerous developmental processes, we observed that the number of detectably expressed genes per cell powerfully associates with cellular differentiation status.
Although previous studies demonstrated a global reduction in chromatin accessibility and/or plasticity during lineage commitment in specific developmental settings [e.g., embryonic stem cells, intestinal stem cells, and neural stem cells (23) (24) (25) ], this work extends the scope of this finding and quantitatively links it to single-cell gene counts. Moreover, as has been previously shown (45) , our results indicate that variability in gene counts between phenotypically identical single cells is not exclusively due to dropout events but is also due to differential sampling of the transcriptome ( fig. S4 ). Our results are therefore consistent with a model in which less-mature cells maintain looser chromatin to permit wider sampling of the transcriptome, whereas more-differentiated cells generally restrict chromatin accessibility and transcriptional diversity as they specialize ( Fig. 1E and fig. S3 ) (46) . Theoretically, this model can be represented by "attractor states" within a genome-wide gene regulatory network (47) . In this context, differentiating cells descend toward stable regions of the network (attractor states), characterized by restricted gene expression, whereas metastable cells broadly sample the network, maintaining higher differentiation potential (47) . Future investigations of this phenomenon, and its relationship to single-cell gene counts, may reveal new mechanisms of stem cell regulation and lineage commitment. However, further studies will be needed to confirm the validity of this model across additional tissue compartments, developmental time points, and phenotypic states.
In summary, we have shown that the number of expressed genes per cell is a hallmark of developmental potential. By exploiting this property of scRNA-seq data, we developed a general framework for resolving single-cell differentiation hierarchies. We envision that our approach will complement existing scRNAseq analysis strategies, with implications for the identification of immature cells and their developmental trajectories in complex tissues throughout multicellular life.
